PAP
DGX icon

Persistent Asset Partners’s Quest Diagnostics DGX Stock Holding History

Persistent Asset Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.9K Buy
+429
New +$84.2K 0.03% 308
2025
Q4 		– Sell
-12,081
Closed -$2.3M – 388
2025
Q3 		$2.3M Buy
12,081
+4,074
+51% +$723K 1.58% 14
2025
Q2 		$1.44M Buy
8,007
+1,168
+17% +$203K 1.07% 26
2025
Q1 		$1.16M Buy
+6,839
New +$1.12M 0.97% 30

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Persistent Asset Partners's DGX Position: Q2 2026 in Review

Persistent Asset Partners opened a new position in Quest Diagnostics (DGX) in Q2 2026: 429 shares worth $90.9K. The stake represents 0.03% of the portfolio and ranks #308 among its holdings. This is a return to the name: Persistent Asset Partners previously reported a position in DGX as recently as Q3 2025.

Persistent Asset Partners first reported a position in DGX in Q1 2025 and has held it in 4 quarters since. The position peaked at $2.3M in Q3 2025. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Persistent Asset Partners held 429 shares of Quest Diagnostics worth $90.9K as of Q2 2026.
  • Quest Diagnostics was a new Persistent Asset Partners position in Q2 2026.
  • Quest Diagnostics made up 0.03% of Persistent Asset Partners's portfolio in Q2 2026, its #308 holding.
  • Persistent Asset Partners first reported a position in Quest Diagnostics in Q1 2025 and has held it in 4 quarters since.
  • Persistent Asset Partners's Quest Diagnostics position peaked at $2.3M in Q3 2025.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.